There is evidence that protein kinase C d (PKCd) is a tumor suppressor, although its physiological role has not been elucidated so far. Since important anti-proliferative signals are mediated by cell ± cell contacts we studied whether PKCd is involved in contact-dependent inhibition of growth in human (FH109) and murine (NIH3T3) ®broblasts. Cell ± cell contacts were imitated by the addition of glutardialdehyde-®xed cells to sparsely seeded ®broblasts. Downregulation of the PKC isoforms a, d, e, and m after prolonged treatment with 12-Otetradecanoylphorbol-13-acetate (TPA, 0.1 mM) resulted in a signi®cant release from contact-inhibition in FH109 cells. Bryostatin 1 selectively prevented TPA-induced PKCd-downregulation and reversed TPA-induced release from contact-inhibition arguing for a role of PKCd in contact-inhibition. In accordance, the PKCd speci®c inhibitor Rottlerin (1 mM) totally abolished contactinhibition. Interestingly, immuno¯uorescence revealed a rapid translocation of PKCd to the nucleus when cultures reached con¯uence with a peak in early-mid G1 phase. Nuclear translocation of PKCd in response to cell ± cell contacts could also be demonstrated after subcellular fractionation by Western blotting and by measuring PKCd-activity after immunoprecipitation. Transient transfection of NIH3T3 cells with a dominant negative mutant of PKCd induced a transformed phenotype. We conclude that PKCd is involved in contact-dependent inhibition of growth. Oncogene (2001) 20, 5143 ± 5154.
Introduction
The proliferation of non-transformed cells is controlled by mitogenic and anti-mitogenic signals. The receptors and downstream eects of mitogenic stimuli exerted by growth factors or growth hormones have extensively been studied during the last decades (Schlessinger and Ullrich, 1992) . It is generally accepted that important anti-mitogenic signals are mediated by cell ± cell contacts, a cellular mechanism which has been described as contact-dependent inhibition of growth or contact-inhibition (Wieser et al., 1990a) . Contactinhibition plays a fundamental role in regulating homeostasis in vivo and in vitro. For example, nontransformed cells in vitro are arrested in G1 phase when they have reached con¯uence. In contrast, tumor cells are characterized by a loss of contact-inhibition which is manifested in vitro by the appearance of crisscrossed growth and foci. Despite its importance for cell cycle control, little is known about the signal transduction pathway of contact-inhibition.
We have recently shown that in human diploid ®broblasts, FH109 cells, contact-inhibition is mediated by the interaction of two cell membrane proteins on adjacent cells, i.e. by the glycoprotein contactinhibin (Wieser et al., 1990b) which binds to its receptor referred to as contactinhibin receptor (Gradl et al., 1995) . Antiproliferative signals from the ligated receptor then lead to G1 arrest by increased association of the tumor suppressor p16 with cdk4 resulting in dissociation of the cyclin D1-cdk4 complex (Wieser et al., 1999) and downstream from increased association of the cdk-inhibitor p27 with the cyclin E-cdk2 complex (Dietrich et al., 1997; Polyak et al., 1994) . As a consequence, the retinoblastoma gene product remains in the hypophosporylated state, thus inhibiting progression into S phase (Dietrich et al., 1997; Polyak et al., 1994; Wieser et al., 1999) . However, upstream events still remain to be elucidated.
There is increasing evidence that PKC, a family of at least 11 isoforms, is not only involved in mitogenesis and tumorigenesis (Borner et al., 1995; LaPorta and Comolli, 1995; Mischak et al., 1993a) , but also in dierentiation (Mischak et al., 1993b) and growth arrest (Borner et al., 1995; Mischak et al., 1993a; Watanabe et al., 1992) . The heterogeneous roles of PKCs displayed in signal transduction pathways are thought to be explained by their distinct tissue distribution and subcellular compartimentalization which cause phosphorylation of individual substrates. For instance, in rat ®broblasts, overexpression of Oncogene (2001) 20, 5143 ± 5154 PKCbI leads to an increased growth rate, higher saturation density and growth in soft agar whereas overexpression of PKCa results in a decreased growth rate and lower saturation density (Borner et al., 1995) . A similar reciprocal eect of two isoforms of PKC has been described by Mischak et al. (1993a) . They observed an increase in proliferation and elevated saturation density as well as soft agar growth after the overexpression of PKCe in NIH3T3 cells. In contrast, overexpression of PKCd led to morphological changes, slower growth rate and decreased saturation density in NIH3T3 cells. It has also been reported that activation of PKCd in CHO (Watanabe et al., 1992) , HL-60 (Griths et al., 1996) , and vascular smooth muscle cells (Fukumoto et al., 1997) results in cell cycle arrest. In accordance, inhibition of PKCd activity in c-src-transfected rat ®broblasts leads to a transformed phenotype characterized by anchorage-independent growth, changes in morphology and increased colony formation eciency . Hence, PKCd is obviously involved in anti-proliferative signals and has been described as a tumor suppressor Perletti et al., 1999) . In addition, it has been reported that PKCd protein expression levels are elevated in con¯uent vascular smooth muscle cells (Fukumoto et al., 1997) , glioma cells (Moreton et al., 1995) and PKCd overexpressing NIH3T3 cells (Lehel et al., 1994) compared to proliferating cells.
In view of the anti-proliferative role of PKCd in overexpression studies as mentioned above, its widespread abundance (Borner et al., 1992; Leibersperger et al., 1990) and upregulation in several cell lines at con¯uence, we hypothesized that PKCd might play a physiological role in mediating the growth inhibitory signals of contact-inhibition. Contact-inhibition was either induced by the addition of glutardialdehyde-®xed cells to sparsely seeded cultures as described previously (Wieser et al., 1999) or by seeding the cells to con¯uence. In the present study we provide strong evidence for a pivotal role of PKCd in contactdependent inhibition of growth in human and murine ®broblasts.
Results

Induction of contact-inhibition by the addition of glutardialdehyde-fixed cells in FH109 cells
We have previously shown that imitating cell ± cell contacts by the addition of glutardialdehyde-®xed cells mimicks the physiological situation occurring in con¯uent cultures (Wieser et al., 1985 (Wieser et al., , 1999 Wieser and Oesch, 1986) . Sparsely seeded FH109 cells were cultured in the presence of 0.5% fetal calf serum (FCS) to achieve partial synchronization and then stimulated with 10% FCS resulting in an 8.4-fold induction of DNA-synthesis (data not shown). Contact-inhibition was induced by the simultaneous addition of glutardialdehyde-®xed ®broblasts (see Figure 1b) . DNAsynthesis was determined by the incorporation of We demonstrated that addition of glutardialdehyde-®xed cells results in 77+5% inhibition of DNA-synthesis which correlates with the reduction of growth rate achieved by seeding the cells to con¯uence (Figure 1a ; see also Wieser et al., 1985) .
Long-term TPA-treatment reduces contact-inhibition in FH109 cells
We ®rst investigated whether downregulation of PKCactivity by long-term phorbol ester treatment in¯uences contact-inhibition. Sparsely seeded FH109 cells were pre-incubated with 12-O-tetradecanoylphorbol-13-acetate (TPA, 0.1 mM) or the inactive isomer 4a-phorbol-12, 13-didecanoate (4a-PDD, 0.1 mM) for 24 h in the presence of 0.5% FCS and then treated with 10% FCS and glutardialdehyde-®xed cells as described above. Inhibition of DNA-synthesis induced by the ®xed cells was reduced to only 30+4% after pretreatment with TPA compared to not pretreated cells with a 72+3% decrease in DNA-synthesis in the presence of ®xed cells. Since the inactive isomer 4a-PDD had no eect we suggested a speci®c action of TPA (Figure 2a) . 
Downregulation of PKC-isoforms after long-term TPA-treatment
Since long-term treatment with phorbol esters results in PKC-degradation , the release of contact-inhibition after TPA-treatment did not seem to be a response of early activation of PKC but rather of depletion of several isoforms caused by prolonged treatment with TPA. In order to specify the action of TPA we analysed which isoforms were downregulated in FH109 cells. Among the expressed isoforms, the proteins of PKCa, PKCd, PKCe, and PKCm were downregulated after 24 h of TPA-treatment ( Figure  2b ). Downregulation of PKCd was paralleled by a shift in the electrophoretic mobility to an apparent molecular weight of 82 kDa. According to the literature we concluded that the 82 kDa species represents a tyrosine phosphorylated form of PKCd (Gschwendt et al., 1994a; Li et al., 1994) , which is assumed to be essential for degradation (Blake et al., 1999) . Our argumentation was supported by the fact that the 82 kDa species of PKCd disappeared after treatment with potato acid phosphatase (data not shown).
Bryostatin 1 prevents downregulation of PKCd and the decrease in contact-inhibition induced by TPA-pretreatment The data presented above suggests that downregulation of either PKCa, PKCd, PKCe or PKCm is responsible for the release from contact-inhibition after prolonged TPA-treatment. Since the compound Bryostatin 1 is known to selectively prevent phorbol ester-induced PKCd-downregulation without any eect on other isoforms in concentrations of 0.1 ± 1 mM (Szallasi et al., 1994; Lorenzo et al., 1997; Lu et al., 1997) we next studied the eect of a coapplication of Bryostatin 1 (1 mM) and TPA. Figure 2a shows that pre-incubation with Bryostatin 1 prevented TPA-induced release from contact-inhibition arguing for a role of PKCd in contact-inhibition. In control experiments we demonstrated that Bryostatin 1 selectively blocked TPAinduced downregulation of PKCd but not of PKCa, PKCm, or PKCe (Figure 2c and data not shown).
Rottlerin but not GoÈ6976 impairs contact-dependent inhibition of growth in FH109 cells
If our hypothesis was correct that PKCd was involved in contact-inhibition then the PKCd-speci®c inhibitor Rottlerin (Gschwendt et al., 1994b) should also cause a (Li et al., 1994) . (c) Total cell extracts of untreated, TPA-pretreated or TPA/Bryostatin 1-pretreated FH109 cells were subjected to immunoblotting with anti-PKCd-or anti-PKCa-antibody. Similar results to PKCa were obtained using anti-PKCe-and anti-PKCmantibodies (data not shown) release from contact-inhibition. In control experiments, the eect of the PKCa/bI-speci®c inhibitor GoÈ 6976 (Gschwendt et al., 1996) was investigated. Rottlerin (1 mM) and Go È 6976 (10 nM) were added simultaneously with the ®xed cells or serum only. While GoÈ 6976 had no eect on contact-inhibition, contact-inhibition was totally abolished in the presence of Rottlerin ( Figure  3a,b) .
However, Rottlerin-treatment led to a 50% decrease in DNA-synthesis in serum-stimulated cells (data not shown). We assumed that the decrease in seruminduced DNA-synthesis was due to inhibition of Calmodulin-dependent protein kinase III. It has been reported that Rottlerin is equieective in inhibiting this kinase (Gschwendt et al., 1994b) hence leading to inhibition of proliferation (Palfrey et al., 1987; Parmer et al., 1997) . Our hypothesis was supported by the fact that the Calmodulin antagonist Tri¯uoperazine (5 mM) decreased DNA-synthesis of serum-stimulated cells to a similar extent but had no eect on contact-inhibition (data not shown).
Rottlerin blocks contact-inhibition during a period of time corresponding to early-mid G1 phase in FH109 cells
In order to further characterize the eect of Rottlerin, we added the inhibitor at dierent time points after the induction of contact-inhibition. We have previously observed that induction of contact-inhibition is limited to mid G1 phase since addition of glutardialdehyde®xed cells 10 h after serum-stimulation no longer results in any growth-inhibition ( Figure 3b ; see also Wieser et al., 1999) .
Rottlerin totally blocked contact-inhibition when added until the ®rst 6 h. When given 10 h after the induction of contact-inhibition, Rottlerin exerted only a reduced eect (Figure 4a ). We knew from¯ow cytometric analysis that cells entered S phase 14 ± 16 h after serum-stimulation (data not shown). Hence, Rottlerin was eective during a time point corresponding to early-mid G1 phase. Progression through G1 phase is mirrored by an increasing phosphorylation of the retinoblastoma gene product (pRB), the gate keeper of S phase entry. Vice versa, in contactinhibited cells, the retinoblastoma gene product is kept in its hypophosphorylated state (Dietrich et al., 1997; Wieser et al., 1999; Figure 4c ). Western blot analysis revealed that the hypophosphorylated species of pRB appeared 6 h after the induction of contact-inhibition and was maximal at 24 h. In parallel, a faster migrating species of PKCd was detected ( Figure 4c ). Since phosphorylation and activation of PKCs result in a decrease in the electrophoretic mobility (Keranen et al., 1995; Stempka et al., 1999) , we concluded that the faster migrating species represented dephosphorylated and hence deactivated PKCd which was con®rmed by treatment with potato acid phosphatase (data not shown) and measuring PKCd-activity (see below). Thus, PKCd dephosphorylation occurs at a time point when pRB is already hypophosphorylated. Interestingly, we observed an approximately twofold increase in total PKCd protein in con¯uent cultures in comparison to proliferating cells.
PKCd is translocated into the nucleus in confluent cells
We next studied intracellular distribution of PKCd by immuno¯uorescence in sparsely seeded (proliferating=p) and con¯uent cultures in comparison to PKCa which was not assumed to be involved in contact-inhibition. In sparsely seeded FH109 cells both, PKCd and PKCa, where exclusively distributed throughout the cytoplasm (Figure 5a,b) . In contrast, we observed a translocation of PKCd into the nucleus in con¯uent cultures (Figure 5c ) while PKCa still could only be detected in the cytoplasm (Figure 5d ).
In order to better understand the relevance of PKCd translocation we mimicked activation of PKCd by short-term treatment with a phorbol ester. After 30 min of TPA-exposure (0.1 mM), PKCd was clearly (Figure 5f ).
Cell ± cell contacts as well as activation of PKCd by short-term phorbol ester-treatment resulted in a nuclear translocation. These observations suggest that PKCd might have a signi®cant role in mediating the signal-transduction of contact-inhibition.
Cell ± cell contacts cause a rapid translocation of PKCd to the nucleus According to the time course studies with Rottlerin described above we expected PKCd to be translocated to the nucleus within the ®rst 6 h in response to cell ± cell contacts. We therefore studied subcellular localization of PKCd at various time points after the induction of contact-inhibition by seeding the cells to con¯uence (Figure 6 ). Since the majority of the cells adhered to the plates 4.5 h after seeding, this time point was de®ned to be the beginning of contact-inhibition (0 h). In sparsely seeded cells, PKCd was exclusively located to the cytoplasm of the ®broblasts (Figure 6a,b) . In accordance to our hypothesis, PKCd was rapidly translocated to the nucleus in con¯uent cells which was maximal 2 ± 6 h after the induction of contactinhibition (Figure 6c ± f). This observation again suggests a function of PKCd in contact-inhibition during early-mid G1 phase.
PKCd-activity increases in the nucleus in response to cell ± cell contacts
To con®rm our data of a nuclear accumulation of PKCd in response to cell ± cell contacts seen in the immuno¯uorescence studies we measured protein levels and kinase activity of PKCd in nuclear extracts. Figure  7a clearly shows an increase in protein levels of PKCd after 2 and 24 h after the induction of contactinhibition in the nucleus of con¯uent compared to sparsely seeded FH109 cells. We then measured PKCd -activity after immunoprecipitation with an anti-PKCdantibody from nuclear extracts of sparsely seeded FH109 cells and con¯uent FH109 cells 2 and 24 h after the induction of contact-inhibition. Kinase activity was measured using histone III-S as substrate Wieser et al., 1999) . (c) FH109 cells were either sparsely seeded (proliferating=p) or to con¯uence (c) in the presence of 10% FCS. The cells were harvested 0, 2, 6, 12, and 24 h after adherence to the culture dish. Equal amounts of total cell extracts (15 mg/lane) were subjected to immunoblotting with anti-pRB-and anti-hPKCd-antibodies. The apparent molecular weights of the proteins are shown on the left. pRB*=hyper-phosphorylated pRB (Dietrich et al., 1997) , PKCd*=phosphorylated PKCd (Stempka et al., 1997) . In perfect consistence with the time course experiments described above (Figures 4  and 6 ), PKCd-activity increased about twofold in the nucleus 2 h after the induction of contact-inhibition compared to sparsely seeded cells, but was only 1.3-fold after another 22 h (Figure 7b) . Hence, our data clearly show, that PKCd is translocated to the nucleus in response to cell ± cell contacts and is active during a time frame corresponding to early-mid G1 phase.
Rottlerin blocks contact-inhibition in NIH3T3 cells
We were then interested if our conclusion that PKCd might be involved in contact-inhibition could be con®rmed in other cell lines. Overexpression of PKCd in NIH3T3 cells results in a slower growth rate and decrease in saturation density (Mischak et al., 1993a) . Additionally, PKCd protein expression levels are elevated in con¯uent PKCd-overexpressing NIH3T3 cells (Lehel et al., 1994) compared with proliferating cells. We therefore postulated that PKCd might mediate contact-inhibition also in NIH3T3 cells and studied the eect of Rottlerin on contact-inhibition in a slightly modi®ed cell culture model described above. NIH3T3 cells were cultured for 24 h in the presence of 10% FCS. Glutardialdehyde-®xed cells were then added in the absence or presence of Rottlerin (1 mM) for 24 h and DNA-synthesis measured thereafter. In the absence of Rottlerin addition of glutardialdehyde®xed cells resulted in a decrease in DNA-synthesis to 54+3.5% (Figure 8a ). The inhibition of proliferation was slightly less than in FH109 cells probably because the NIH3T3 cells were not synchronized. In NIH3T3 cells, Rottlerin-exposure (1 mM) led to a decrease in DNA-synthesis by 43+7% (data not shown) and totally blocked contact-dependent inhibition of growth (Figure 8a ).
PKCd protein expression levels are elevated in confluent NIH3T3 cells
We next analysed whether endogenous PKCd protein levels might be in¯uenced by cell ± cell contacts as suggested by our observation in FH109 cells and overexpression studies as mentioned above (Lehel et al., 1994) . Indeed, Western blot analysis revealed a signi®cant elevation of PKCd protein levels in conuent cells (Figure 8b ).
Expression of a dominant negative mutant of PKCd results in a transformed phenotype
To gain more information about the role of PKCd in contact-inhibition, a dominant negative mutant of PKCd was transiently transfected into NIH3T3 cells. In this mutant (Hirai et al., 1994) two Arg are converted to Ala (DR144/145A) in the pseudo substrate region thus enabling substrate binding. A further Lys to Ala mutation (DK376A) in the ATP binding region is responsible for the dominant negative eect. Since PKCd is expressed endogenously at low levels in NIH3T3 cells we clearly could discriminate In view of the fact that disruption of the actin cytoskeleton by cytochalasin D induces release from contact-inhibition in con¯uent FH109 cells (unpublished observation) we conclude that an intact actin cytoskeleton is required for contactinhibition. We propose that one mechanism of PKCd function is regulation of the actin cytoskeleton to ensure contact-dependent inhibition of growth.
Discussion
The purpose of the present study was to gain more insight into the signal transduction pathway of contactinhibition, and we speci®cally addressed the question whether PKC might be involved in contact-dependent For studying contact-inhibition we used a cell culture model which had been established previously. Contact-inhibition was induced by the addition of glutardialdehyde-®xed cells to sparsely seeded cultures in the presence of serum. We have demonstrated that this system mimicks physiological conditions concerning cell cycle arrest and dierentiation (Wieser et al., 1985 (Wieser et al., , 1999 Wieser and Oesch, 1986) . The advantages of this system are the possibility to perform time course studies and the avoidance of artifacts, e.g. due to serum-deprivation when the cells grow to con¯uence.
Several lines of evidence led us to conclude that PKCd is involved in contact-dependent inhibition of growth.
Protein expression levels of PKCd are elevated in con¯uent FH109 and NIH3T3 cells suggesting that PKCd expression is regulated by cell ± cell contacts. Consistently, the same observation has been reported for PKCd overexpressing NIH3T3 (Lehel et al., 1994) , vascular smooth muscle (Fukumoto et al., 1997) and glioma cells (Moreton et al., 1995) . Taking into account that overexpression of PKCd in the same cell lines results in a marked growth inhibition (Fukumoto et al., 1997; Hirai et al., 1994; Mischak et al., 1993a; Mishima et al., 1994) it is reasonable to propose an anti-proliferative role of PKCd in response to cell ± cell contacts.
If our hypothesis had been correct then inhibition of PKCd should result in a release from contactinhibition. This was shown for both cell lines by Rottlerin, a compound isolated from Mallotus philippinensis which speci®cally inhibits PKCd probably by competing with the ATP binding site (Gschwendt et al., 1994b) . Other PKC isoforms proved to be at least one order of magnitude less sensitive for this inhibitor (i.e. a-isoform: IC 50 : 30 mM; e-isoform: IC 50 : 100 mM). In the presence of Rottlerin contact-inhibition is totally abolished whereas no release from contact-inhibition can be detected in the presence of the PKCa/b1-speci®c inhibitor GoÈ 6976 (Gschwendt et al., 1996) . The eect of Rottlerin is reversible when washed out (unpublished observation) and restricted to early-mid G1 phase hence speaking for a non-toxic, speci®c action on PKCd. Although the concentrations used in dierent systems cannot be exactly compared, the concentration of 1 mM used in our experiment is similar to the IC 50 value of 3 ± 6 mM described for in vitro assays arguing for a speci®c inhibition of PKCd and no other PKC isoforms.
Although we cannot rule out an inhibitory eect of Rottlerin on yet unknown kinases, our assumption was supported by the fact that prolonged TPA-pretreatment resulting in PKC-depletion also reduced contactinhibition. TPA-induced release from contact-inhibition could be prevented by coapplication with Bryostatin 1. Bryostatin 1 is known to have a biphasic dose-response curve and to selectively prevent TPAinduced downregulation of PKCd in concentrations of 0.1 ± 1 mM (Lorenzo et al., 1997; Lu et al., 1997; Szallasi et al., 1994; and this study) .
Studying subcellular distribution further argued for our conclusion that PKCd-activity is crucial for contact-dependent inhibition of growth. To our knowledge the present study is the ®rst results demonstrating a nuclear translocation of a PKC isoform due to cell ± cell contacts. Since PKCa which was not assumed to be involved in contact-inhibition showed no translocation to any subcellular compartment under these conditions we concluded that translocation of PKCd was a speci®c response to cell ± cell contacts. In addition, the time course of nuclear translocation with a maximum within the ®rst 2 ± 6 h after the induction of contact-inhibition is consistent with the maximum of Rottlerin action. Accordingly, we observed a gradual inactivation of PKCd by dephosphorylation (re¯ected by an increased electrophoretic mobility) with similar kinetics and correlating with the hypophosphorylation of pRB. In perfect agreement with these kinetic studies PKCdactivity is shown to be twofold higher in nuclear extracts 2 h after the generation of cell ± cell contacts compared to sparsely seeded cells and is only 1.3-fold higher after another 22 h.
Activation of PKCd by short-term phorbol estertreatment also leads to a signi®cant translocation into the nucleus. This is in accordance with the observation that activation of PKCd by short-term treatment with TPA results in a decrease in proliferation in sparsely seeded FH109 cells (Oesch et al., 1988) . Nuclear translocation caused by cell-cell contacts is therefore consistent with PKCd-activation and cell cycle arrest.
The precise role of PKCd in contact-inhibition is not known so far. One possibility of PKCd action is aecting cell cycle regulatory proteins such as cyclindependent kinases. Fukumoto et al. (1997) , have reported that overexpression of PKCd in rat vascular smooth muscle cells leads to downregulation of cyclin D1 and cyclin E as well as upregulation of the cdk inhibitor p27. In human diploid ®broblasts, phorbol ester-treatment causes G1 arrest probably due to a decrease in cdk7 and cyclin H protein levels (Hamada et al., 1996) . However, further investigations are neccessary to elucidate the eect of PKCd in FH109 and NIH3T3 cells on cell cycle regulatory proteins.
The severe change in morphology accompanied by disruption of actin stress ®bers of the dominant negative mutants and after Rottlerin-treatment led us to conclude that one possible target of PKCd is the cytoskeleton. Interestingly, two speci®c downstream targets of PKCd, HSP27 (Maizels et al., 1998) and the elongation factor eEF-1a (Kielbassa et al., 1995) , have both actin stabilizing functions (Condeelis, 1995; Guay et al., 1997; Yang et al., 1990) . We also know, that an intact actin cytoskeleton is required for contactinhibition since cytochalasin D-treatment induces a release from contact-inhibition in con¯uent FH109 cells. We therefore suggest that one possible role of PKCd is regulation of the actin cytoskeleton to ensure proper contact-inhibition.
We also wish to point out that transfecting NIH3T3 cells with dominant negative PKCd results in the same phenotype characterized by disruption of actin stress ®bers as described for oncogenic ras-transfected NIH3T3 cells (Ueberall et al., 1999 and references therein) . A similar actin reorganization has been detected in src-transfected murine ®broblasts (Chang et al., 1995) . Accordingly, a correlation between rasor src-action and PKCd-deactivation has been reported. For instance, PKCd degradation is observed after PDGF-stimulation in NIH3T3 cells (Blake et al., 1999) , after src-transfection in rat ®broblasts and in response to ras-transfection in HaCaT cells (Geiges et al., 1995) . Consistent with the later observation we have demonstrated that loss of contact-inhibition in response to Rottlerin treatment is not restricted to ®broblasts but is also observed in HaCaT cells (Dietrich et al., 2001) . Hence, transformation by ras or src is coupled with a loss of PKCd function in several cell lines strongly arguing for a pivotal role of PKCd in cell cycle control. Here we provide strong evidence that PKCd is crucial for cell cycle control mediated by cell ± cell contacts.
In summary, we provide strong evidence that PKCd is involved in contact-inhibition. We describe for the ®rst time a physiological role of PKCd in cell cycle control which is in accordance with the following observations: (i) activation of PKCd results in a cell cycle arrest in G1 in various cell types (Fukumoto et al., 1997; Griths et al., 1996; Mischak et al., 1993a) , (ii) downregulation or inhibition of PKCd in c-src transfected rat ®broblasts leads to a transformed phenotype , (iii) PKCd is upregulated in con¯uent cultures (Fukumoto et al., 1997; Lehel et al., 1994; Moreton et al., 1995;  and this study), (iv) PKCd is downregulated in a two stage model of liver carcinogenesis (LaPorta et al., 1997) , and PKCd acts as a tumor suppressor (LaPorta and Comolli, 1995; Perletti et al., 1999 , for review see Gschwendt, 1999) . We are currently investigating downstream targets of PKCd to gain further insight into its role in contactinhibition.
Materials and methods
Cells and cell culture
FH109 human embryonal lung ®broblasts (Wieser et al., 1985) and NIH3T3 ®broblasts were cultured in Dulbecco's modi®ed Eagle's medium (DMEM, PAN) supplemented with 10% fetal calf serum (FCS, Greiner).
Induction of contact-inhibition
Contact-inhibition was induced by the addition of glutardialdehyde-®xed cells to sparsely seeded cultures as described previously (Wieser et al., 1985; Wieser and Oesch, 1986) . Brie¯y, con¯uent monolayers of either FH109 or NIH3T3 cells were trypsinized, washed with phosphate buered saline (PBS) and ®xed by the dropwise addition of glutardialdehyde (Sigma). 5610 3 FH109 cells/well were seeded into microtiter plates and cultured for 24 h in DMEM/0.5% FCS to achieve partial synchronization. Control cells were then stimulated with 10% FCS Contact-inhibition was then induced by the addition of the glutardialdehyde-®xed cells (1.5610 5 /cm 2 ) in DMEM/10% FCS. After additional 24 h DNA-synthesis was determined. TPA (0.1 mM, Sigma), 4a-PDD (0.1 mM, Sigma), Bryostatin 1 (1 mM, Biomol), Rottlerin (1 mM, Roth), and GoÈ 6976 (10 nM, Calbiochem) were added as described in the ®gure legends. 
Total cell extracts
To study downregulation of PKC isoforms 5610 5 FH109 cells were seeded into 60 mm dishes and cultured for 24 h in DMEM/0.5% FCS, in the absence or presence of TPA (0.1 mM) or 4a-PDD (0.1 mM). For time course studies, FH109 cells were plated at a cell density of 3.5610 6 /60 mm dish in DMEM/10% FCS and harvested 2, 6, 12 and 24 h after adherence which was determined to be 4.5 h after plating. Cells were lysed in 500 ml of hot Laemmli sample Involvement of PKCd in contact-inhibition I Heit et al buer (Laemmli, 1970) and protein concentration was determined according to Smith et al. (1985) .
Western blotting
Proteins were separated by SDS ± PAGE (7.5%) and electroblotted overnight onto Immobilon membranes (Millipore). The membranes were blocked for 1 h with 5% low fat milk powder in TBS (50 mM Tris/HCl, pH 7.5, 150 mM NaCl) containing 0.05% Tween 20 and then incubated for 1.5 h at room temperature with anti-PKC antibodies (PKCa 1 : 2000, UBI; hPKCd 1 : 3000; mPKCd 1 : 1000, PKCe 1 : 2000; PKCm: 1 : 200, each Santa Cruz) or anti-pRB antibody (1 : 2000, Santa Cruz). Secondary antibodies (antimouse-or anti-rabbit-alkaline phosphatase-conjugated antibodies, 1 : 3000, Cedarlane) were added for additional 1 h. 4-Nitroblue tetrazolium chloride and 5-bromo-4-chloro-3-indolyl phosphate (both Roche Biochemicals) were used as detection system.
Nuclear extracts
3610 7 FH109 cells were either sparsely seeded or seeded to con¯uence and trypsinized after 2 and 24 h. Cells were lysed for 10 min at 48C (10 mM HEPES/NaOH pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 300 mM saccharose, 1 mM EDTA, 1 mM DTT, protease and phosphatase inhibitors as described (Dietrich et al., 1996) and resuspended with a 22 gauge needle. Nuclei were pelleted by centrifugation at 400 g and solubilized either in hot Laemmli sample buer for subsequent Western blotting or for 30 min at 48C in lysis buer (20 mM HEPES/NaOH pH 7.9, 420 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 25% (v/v) glycerol) for subsequent immunoprecipitation.
Immunoprecipitation and kinase assay
Six hundred milligrams of nuclear extracts were incubated with 4 mg of anti-hPKCd-antibody covalently coupled to protein A-Sepharose (40 ml suspension 1 : 1 in PBS) at 48C overnight. PKCd-activity was measured in a total volume of 100 ml in a buer containing of 20 mM Tris/HCl pH 7.5, 4 mM MgCl 2 , 20 mM b-mercaptoethanol, 10 mg of phosphatidylserine, 1 mM TPA, 37 mM ATP, 72 kBq of [g-33 P]ATP (Hartmann Analytic, Braunschweig, Germany) and 5 mg of histone III-S (Sigma) as substrate according to (Stempka et al., 1997) . After incubation for 10 min at 308C, 50 ml of the reaction mixture was transferred onto phosphocelluose paper (Whatman p81) and radioactivity was determined by liquid scintillation spectrometry.
Immunofluorescence
Cells were seeded on glass coverslips at a density of either 2.5610 5 /60 mm dish (proliferating) or 3.5610 6 /60 mm dish (con¯uent) in DMEM/10% FCS. Time point 0 h was de®ned at 4.5 h after seeding when the cells adhered to the dish. Immuno¯uorescence was performed at 2, 6, 12, and 24 h after adherence for time course studies. Alternatively, 2.5610 5 cells were cultured for 24 h in DMEM/10% FCS and then treated with TPA (0.1 mM) for 30 min. Cells were then ®xed with acetone at 7208C for 5 min. The coverslips were air-dried and washed three times with PBS. Unspeci®c binding was suppressed by blocking overnight at 48C with 5% bovine serum albumin in PBS. The cells were then incubated with anti-PKCd antibody in PBS (1 : 200, Santa Cruz) for 1.5 h at room temperature. After three short and three 5-min washing steps, incubation with Cy3-conjugated anti-rabbit antibody in PBS (1 : 300, Jackson Immunoresearch) for 1 h at room temperature was performed. The cells were again washed as described and the coverslips mounted on glass slides in a medium consisting of 17% Mowiol 4-88 (Hoechst) and 20% glycerin in 0.15% Tris/HCl, pH 8.5. Speci®c binding of the anti-PKCd antibody was shown by preincubation with a PKCd-blocking peptide (Santa Cruz, data not shown). Actin ®lament staining was performed with FITC-conjugated phalloidin (25 mg/ml, Sigma). The cells were viewed on a Microphot-FXA Nikon microscope with excitation wavelength of 490 nm (FITC) and 550 nm (Cy3).
Transfection
A dominant negative mutant of PKCd (kindly provided by Shigeo Ohno) was transiently expressed in NIH3T3 cells using the liposomic transfection reagent Roti 1 -fect (Roth, Germany). Cells were plated at a density of 5610 5 cells/ 35 mm dish in DMEM/10% FCS. After 24 h the cells were washed with PBS and incubated for 6 h with the DNA-lipid complexes (3 mg DNA, 25 ml Roti 1 -fect) according to the manufacturer's instructions. The cells were characterized 48 h after transfection by immuno¯uorescence using an antimPKCd-antibody as described above.
